Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. - Wikidata - awgldk - TriplyDB

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

http://www.wikidata.org/entity/Q34150320

about

Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.Inflammation induced loss of skeletal muscle Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha UCP3 in muscle wasting, a role in modulating lipotoxicity?Sarcopaenia and rheumatoid arthritis.The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients.Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.An extensive phenotypic characterization of the hTNFalpha transgenic mice.Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment.Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.Protein-energy malnutrition in older subjects.Transition to sarcopenia and determinants of transitions in older adults: a population-based study Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication Investigation of antiarthritic potential of Plumeria alba L. leaves in acute and chronic models of arthritis Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation Resting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study.One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.Association of physical function and physical activity in women with rheumatoid arthritis.Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.Are persons with rheumatoid arthritis deconditioned? A review of physical activity and aerobic capacity.Benefits of exercise in rheumatoid arthritis Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline.A close association of body cell mass loss with disease activity and disability in Chinese patients with rheumatoid arthritis.An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis.Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Growth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis.Volumetric bone mineral density and bone structure in childhood chronic kidney disease Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation Redefining overweight and obesity in rheumatoid arthritis patients.Body composition in patients with rheumatoid arthritis is not different than healthy subjects Physical activity and modulation of systemic low-level inflammation.Bone loss in Crohn's disease: exercise as a potential countermeasure.Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study A Novel Analytic Technique to Measure Associations Between Circulating Biomarkers and Physical Performance Across the Adult Life Span.

P2860

Q24812557-23A44622-D931-4BF6-8B82-6E84F0C93F3B Q26823313-9E858DC2-979E-4EB1-B040-EDC8A62DAA2E Q28083759-E9C20CB7-359B-46DB-98C0-7247F3EF9A05 Q28365498-7D071763-54A4-4EF8-A5A5-B64547485DDB Q28568690-0B2796CE-9AE4-4490-B85C-384F57A0222A Q30234376-34A13D5D-E7C9-4C02-911D-B820B9769B91 Q31978689-7C418A02-64B4-4058-8520-D28F90756BA1 Q33307666-4EECAD2E-780A-4B3F-A99F-B02C5FD52E35 Q33309488-483BEB30-FCAB-4A25-B9A8-B0993A8FB650 Q33444754-B0635845-B1B0-4220-8348-3FA18C21D8D9 Q33459510-A042B3FD-B301-4300-B97B-3C2DFF4031EE Q33545961-B8053ED6-8B6C-473A-BB00-F06B0AD8BF93 Q33616020-40149D7B-5BE0-480F-8D4A-479C9A1C0AF9 Q33792588-7DA20846-C836-4577-8AAD-7B1845CA4A01 Q33849729-4CA83D5D-6388-4E08-B20D-62FFBF8DABAC Q33887434-641211D0-BE1A-47F8-A5B0-98926E436A67 Q33912921-55A5DF53-CB67-4045-B05A-4F6746871D66 Q34034275-CDB1B1AD-2EFD-4B2A-AFDA-25E00076F5EE Q34063456-5E4F4DBF-AE28-4884-8EBB-B5CC563AE8F3 Q34200939-ACD2CCC8-0138-4305-89DE-CF71D6D72015 Q34333249-EEC10C4B-3BD7-4291-B585-8CAF8C8EE86C Q34389006-2EA17C10-7C35-47D8-9CB6-7777FC6B96B6 Q34451231-CA4137F2-C035-4E07-AAE3-38928A41677F Q34591298-4A166403-F069-43AF-8BA3-9B24969B69ED Q34802678-58B2F5D2-9A5C-4A35-A427-F5F8C0C9B791 Q35042613-80ED82C5-144F-41C1-B690-EDAB62EE53E4 Q35141960-5BA9FFA1-3907-42D3-BEA4-D399B519C13F Q35552423-2516F4AC-5424-4BB7-81A5-27364756A646 Q35555818-14BA7457-A978-456E-8941-13B1B7F1F4C9 Q35556074-CBD6C55F-8423-4BD2-8394-E344E2F1C994 Q35596467-CD75CA1A-FD0C-42B8-8AD8-4CE3EAFF099A Q35755313-5FC155E0-BA09-4990-974C-14F908E59AA0 Q35832409-B6F19F5C-6EEE-4A67-A57B-DF4623746C8E Q35966135-1662339B-CCB9-47DE-AAF1-1439A6FB6371 Q36013923-53ED3847-71E1-4F1A-A75A-F234543D89C6 Q36154527-306A84FA-B426-4ADC-B838-60F40A15DD08 Q36201980-0420B3FD-0D6A-4608-B690-7F4710A4006B Q36321697-3357842C-21BB-420E-BE2D-A23E1A330B84 Q36392385-3F97FAFB-919E-43F1-BFAA-E00CEEE64A15 Q36492364-5D1B7910-A3D5-495B-9B06-785551D52DBD

P2860

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

http://www.wikidata.org/entity/Q34150320

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@ast

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@en

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@nl

type

label

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@ast

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@en

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@nl

prefLabel

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@ast

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@en

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@nl

P1433

Q34150320-5EDA0A13-DE00-4B7E-859C-74761FA11438

P1476

Q34150320-EFD5BD80-BAAB-40CE-BB09-4F09CD9201CE

P2093

Q34150320-0BB264A9-8CEC-4A61-8E07-A4E61E7D9D64

Q34150320-36840435-8765-485F-8A9C-F5B95985A915

Q34150320-3D3EF24B-D2D2-42B2-92E1-A144DA988245

Q34150320-43782560-02B6-47F6-8DE4-8E9CAE99B93C

Q34150320-8E43ABD9-3AD5-41EC-AF0E-D03930D42BEB

Q34150320-97A73EBE-8247-4905-8EFE-6338FC1E7157

Q34150320-9CD6B873-3E30-4438-B0C7-B0B86E764E02

Q34150320-F8E9BB16-F592-4C74-BB5F-E115BA8EFF98

P2860

Q34150320-0A5EDA23-CA28-483C-9153-8A344C7496A1

Q34150320-0C090AFA-722A-4F5D-81FB-1A018CB7916A

Q34150320-1728536B-EFCA-4A7D-AF66-0502372657D0

Q34150320-20EE437C-5E4E-4035-A69E-52B67B670217

Q34150320-232DB41E-83F9-4E00-A601-7432D93921BD

Q34150320-255770EF-71A9-4625-A1C5-AED0B08466A4

Q34150320-33210CD0-443E-4749-8C44-92284365CE13

Q34150320-332F011A-842B-48AC-9445-1F7ED2422548

Q34150320-35C3C268-D987-4287-A498-3F59B525644A

Q34150320-436728DB-59A1-4225-A6BA-3D57CA9DAF47

P304

Q34150320-F5EEC818-1062-4BB1-B48B-B1FB27A7B652

P31

Q34150320-D3C74DDD-3265-4BAF-8645-CCB00C67128B

P356

Q34150320-8AE488DD-7F43-41F0-B62F-C5CB723544DC

P407

Q34150320-EF6D07B5-F336-4811-9160-55EF1BAC9D4C

P433

Q34150320-D43BE8BA-B46F-4877-A02B-ED892E991828

P478

Q34150320-303DC05E-A800-4681-B7BA-037211DF17B7

P577

Q34150320-751219C0-1224-40D6-946B-7C91024D5E2E

P698

Q34150320-682BAC70-BA8D-43F7-A38F-E6D5ED7B8AB5

P921

Q34150320-66522A18-9DE6-411A-AB10-8BF503D63B91

P932

Q34150320-49AA27C1-CD97-4B46-80AB-28B2239E89D6

P356

P1433

Journal of Clinical Investigation

P1476

Rheumatoid cachexia: cytokine- ...... mass in chronic inflammation.

@en

P2093

B Dawson-Hughes

http://www.w3.org/2001/XMLSchema#string

C A Dinarello

http://www.w3.org/2001/XMLSchema#string

H Zhuang

http://www.w3.org/2001/XMLSchema#string

I H Rosenberg

http://www.w3.org/2001/XMLSchema#string

J G Cannon

http://www.w3.org/2001/XMLSchema#string

J J Kehayias

http://www.w3.org/2001/XMLSchema#string

R A Roubenoff

http://www.w3.org/2001/XMLSchema#string

R Roubenoff

http://www.w3.org/2001/XMLSchema#string

P2860

Starvation in man

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

A data-based approach to diet questionnaire design and testing.

Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.

Physical activity, all-cause mortality, and longevity of college alumni.

New methods for calculating metabolic rate with special reference to protein metabolism.

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins.

Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

P304

2379-2386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117244

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8200971

http://www.w3.org/2001/XMLSchema#string

P921

P932

294444

http://www.w3.org/2001/XMLSchema#string